Wang Chunqiang, Huang Tianye, Wang Xuebing
Department of Anorectal Surgery, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, Zhejiang 311200, P.R. China.
Department of Anorectal Surgery, Linyi Central Hospital, Linyi, Shandong 276401, P.R. China.
Exp Ther Med. 2024 May 31;28(2):306. doi: 10.3892/etm.2024.12595. eCollection 2024 Aug.
The best treatment of high complex anal fistula (HCAF) is to avoid anal incontinence while improving the cure rate. On this basis, several surgical procedures for preserving the anal sphincter have been proposed. The purpose of the present study was to evaluate the efficacy and safety of transanal opening of intersphincteric space for treating HCAF. PubMed, Cochrane Library, China National Knowledge Infrastructure and the Wanfang databases were searched to collate all the articles on transanal opening of intersphincteric space for treating HCAF. A total of two researchers independently completed the whole process, from screening and inclusion to data extraction and the data was included in the RevMan 5.3 software for analysis. The main outcomes included the patients' essential characteristics, primary healing rate, management after recurrence, final healing rate, anal incontinence score before and after surgery, postoperative complication rate and types of complications. A total of six articles were included in this meta-analysis. The results showed that the weighted final healing rate of patients following transanal opening of intersphincteric space was 89% [risk differences (RD)=0.89; 95% confidence interval (CI)=0.86-0.92; I=0%; P<0.00001]. The results of the anal incontinence score showed that there was no significant difference between the results before and after transanal opening of intersphincteric space surgery mean differences [(MD)=-0.04, Cl=-0.10-0.02, I=0%; P=0.21]. Only 11 patients were reported to have complications, including urinary retention and bleeding following transanal opening of intersphincteric space with a complication rate of 8% (11/138) and the weighted average complication rate was 6% (RD=0.06,95% CI=0.02-0.10; I=9%; P=0.003). Transanal opening of intersphincteric space has a high cure rate, a favorable anal incontinence score, fewer types of postoperative complications and a low complication rate; it can be used as a minimally invasive and sphincter-preserving surgical method for treating HCAF and is worthy of further promotion and research in clinical practice.
高位复杂性肛瘘(HCAF)的最佳治疗方法是在提高治愈率的同时避免肛门失禁。在此基础上,人们提出了几种保留肛门括约肌的手术方法。本研究的目的是评估经肛门开放括约肌间间隙治疗HCAF的有效性和安全性。检索了PubMed、Cochrane图书馆、中国知网和万方数据库,以整理所有关于经肛门开放括约肌间间隙治疗HCAF的文章。共有两名研究人员独立完成了从筛选、纳入到数据提取的全过程,并将数据纳入RevMan 5.3软件进行分析。主要结果包括患者的基本特征、一期愈合率、复发后的处理、最终愈合率、手术前后的肛门失禁评分、术后并发症发生率及并发症类型。本荟萃分析共纳入6篇文章。结果显示,经肛门开放括约肌间间隙后患者的加权最终愈合率为89%[风险差异(RD)=0.89;95%置信区间(CI)=0.86 - 0.92;I²=0%;P<0.00001]。肛门失禁评分结果显示,经肛门开放括约肌间间隙手术前后的结果无显著差异[平均差异(MD)=-0.04,CI=-0.10 - 0.02,I²=0%;P=0.21]。仅报告有11例患者出现并发症,包括经肛门开放括约肌间间隙后的尿潴留和出血,并发症发生率为8%(11/138),加权平均并发症发生率为6%(RD=0.06,95%CI=0.02 - 0.10;I²=9%;P=0.003)。经肛门开放括约肌间间隙治愈率高,肛门失禁评分良好,术后并发症类型较少且发生率低;可作为一种治疗HCAF的微创保括约肌手术方法,值得在临床实践中进一步推广和研究。